A detailed history of New England Research & Management, Inc. transactions in Danaher Corp stock. As of the latest transaction made, New England Research & Management, Inc. holds 2,405 shares of DHR stock, worth $583,982. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,405
Previous 3,810 36.88%
Holding current value
$583,982
Previous $952,000 29.73%
% of portfolio
0.31%
Previous 0.46%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$239.25 - $280.76 $336,146 - $394,467
-1,405 Reduced 36.88%
2,405 $669,000
Q2 2024

Jul 09, 2024

SELL
$235.51 - $267.98 $11,775 - $13,399
-50 Reduced 1.3%
3,810 $952,000
Q1 2024

Apr 16, 2024

SELL
$224.58 - $256.19 $11,229 - $12,809
-50 Reduced 1.28%
3,860 $964,000
Q4 2023

Feb 06, 2024

SELL
$185.1 - $233.13 $402,777 - $507,290
-2,176 Reduced 35.75%
3,910 $905,000
Q3 2023

Oct 10, 2023

SELL
$233.08 - $265.59 $241,237 - $274,885
-1,035 Reduced 14.53%
6,086 $1.51 Million
Q2 2023

Jul 05, 2023

BUY
$224.99 - $256.14 $698,593 - $795,314
3,105 Added 77.32%
7,121 $1.71 Million
Q1 2023

Apr 06, 2023

BUY
$239.75 - $277.0 $2,397 - $2,770
10 Added 0.25%
4,016 $1.01 Million
Q4 2022

Jan 09, 2023

BUY
$241.42 - $282.29 $175,029 - $204,660
725 Added 22.1%
4,006 $1.06 Million
Q3 2022

Oct 06, 2022

BUY
$247.06 - $1507.4 $810,603 - $4.95 Million
3,281 New
3,281 $847,000
Q4 2017

Jan 09, 2018

SELL
$85.26 - $94.62 $260,043 - $288,591
-3,050 Closed
0 $0
Q3 2017

Oct 25, 2017

BUY
$79.29 - $88.45 $241,834 - $269,772
3,050
3,050 $262,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.